tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Income Statement

Compare
1,497 Followers

Ocular Therapeutix Income Statement

Last quarter (Q3 2025), Ocular Therapeutix's total revenue was $14.54M, a decrease of -5.71% from the same quarter last year. In Q3, Ocular Therapeutix's net income was $-69.42M. See Ocular Therapeutix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 63.72M$ 58.44M$ 51.49M$ 43.52M$ 17.40M
Gross Profit
$ 58.10M$ 53.16M$ 46.95M$ 39.12M$ 15.32M
Operating Expenses
$ 229.88M$ 135.54M$ 125.61M$ 117.15M$ 78.17M
Depreciation and Amortization
$ 3.79M$ 2.98M$ 2.11M$ 2.42M$ 2.77M
EBITDA
$ -176.14M$ -66.42M$ -61.91M$ 2.54M$ -146.09M
Operating Income
$ -171.78M$ -82.38M$ -78.65M$ -78.04M$ -62.85M
Other Income/Expenses
$ -21.73M$ 1.65M$ 7.62M$ 71.48M$ -92.79M
Pretax Income
$ -193.51M$ -80.74M$ -71.04M$ -6.55M$ -155.64M
Net Income
$ -193.51M$ -80.74M$ -71.04M$ -6.55M$ -155.64M
Per Share Metrics
Basic EPS
$ -1.22$ -1.09$ -1.04$ -1.05$ -2.56
Diluted EPS
$ -1.22$ -1.02$ -0.97$ -0.98$ -2.56
Weighted Average Shares Outstanding
158.26M 79.83M 76.88M 76.39M 60.75M
Weighted Average Shares Outstanding (Diluted)
158.26M 85.60M 82.64M 82.16M 60.75M
Currency in USD

Ocular Therapeutix Earnings and Revenue History